← Evidence map

ArticleMultiple sclerosis and related disorders2025

Retraction Notice to "New relapse of multiple sclerosis and neuromyelitis optica as a potential adverse event of AstraZeneca AZD1222 vaccination for COVID-19" [Multiple Sclerosis and Related Disorders 57 (2022) 103321].

Yara D Fragoso et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Retraction Notice to "New relapse of multiple sclerosis and neuromyelitis optica as a potential adverse event of AstraZeneca AZD1222 vaccination for COVID-19" [Multiple Sclerosis and Related Disorders 57 (2022) 103321]. | OpenQuestion